Household cleaners, personal care products, perfumes, and other consumer and industrial products emit chemicals known as volatile organic compounds, or VOCs. Researchers led by scientists from the National Oceanic and Atmospheric Administration found that as cars have gotten cleaner, tailpipe emissions have gone down. As a result, the researchers estimate that emissions from consumer and industrial products now contribute half of the VOCs that cause air pollution.
Wireless internet, cell phones, and smart meters are ubiquitous in the modern world, but some studies have shown that there is reason to be cautious about exposure to microwave radiation (MWR). The federal government, however, is not only asleep at the wheel; it has preempted local communities from rejecting cell phone towers based on very real health concerns. It’s time for federal regulators to take this issue seriously and stop blocking citizens from stepping in when the government fails to act.
The word is out about bisphenol-A (BPA), the chemical that is commonly used in drinking containers, children’s toys, and other plastic products: it’s been linked to diabetes, asthma, cancer, obesity, and altered prostate and neurological development, among other illnesses. Unfortunately, the alternatives that industry is using are no safer, despite the “BPA-free” marketing ploys—but federal regulators continue to protect the chemical industry by refusing to ban these dangerous compounds.
While there have been many breakthroughs in cancer treatment heralded by the media in recent years – most notably the advances in immunotherapy and combination therapies – the considerable advances in ablation technology and resulting impact on patient survival, have consistently slipped beneath the radar.
You may have heard “endocrine disruptors” mentioned in association with certain cancers, like breast cancer. But do you know what they are and where they lurk in your food, home and personal care products? And do you know why it matters to your health?
The study found that for women with hormone receptor (HR)-positive, HER2-negative, axillary lymph node–negative breast cancer, treatment with chemotherapy and hormone therapy after surgery is not more beneficial than treatment with hormone therapy alone. The new data, released at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, will help inform treatment decisions for many women with early-stage breast cancer.
It’s not clear what causes chemo brain, and no cure has been identified. In most cases, cancer-related memory problems are temporary, so treatment focuses on coping with symptoms. No standard treatment has been developed for cancer-related memory problems. Because symptoms and severity differ from person to person, your doctor can work with you to develop an individualized approach to coping.
A new study shows that the cells surrounding the breast’s milk ducts form an active barrier that extends and grabs cancer cells before they spread to the rest of the body.
To try to develop more effective immunotherapies, two groups of researchers, working independently, have developed a type of drug that simultaneously targets two proteins involved in suppressing the body’s immune response against tumors.
Gene expression profiling tests (Oncotype DX, MammaPrint, others) analyze a number of different genes within your cancer cells to predict your risk of cancer recurrence.
The results of gene expression profiling tests help doctors determine who may benefit from additional (adjuvant) treatment after surgery. For women with early-stage breast cancer that is sensitive to hormones, gene expression profiling tests are used to determine whether they are likely to benefit from adjuvant chemotherapy.
Tallying microplastics, let alone halting them in their tracks, struck me as a Sisyphean task. Even when more data about microplastics does come into clear view, there will still be nanoplastics to contend with. These are generally accepted to be particles smaller than one micron, Dimitrijevic says. (A human hair and a single leaf of paper are both significantly thicker.) How do you grapple with a problem that’s everywhere, and invisible, and so difficult to wrangle or keep hold of? “Doing these projects, yeah, I don’t anticipate that it’s going to be an uplifting discovery or finding,” Roble told me, up on the dock. But she thinks that data and education are a place to start.